A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT04166773 · COMPLETED
Trial details
- NCT number
- NCT04166773
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-19
- Primary completion
- 2023-12-11
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.